Genomictree Inc. (KOSDAQ:A228760) announces a share repurchase program. Under the program, the company will repurchase up to KRW 5,000 million worth of its shares pursuant to a contract with Mirae Asset Securities Co., Ltd. The purpose of the share repurchase is stock price stability and to enhance shareholder value. The repurchase program will expire on November 16, 2022.

As of May 16, 2022, the company had no shares within scope available for dividend and had no shares in treasury through other repurchase.